Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury - Trial NCT06330935
Access comprehensive clinical trial information for NCT06330935 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Mansoura University and is currently Recruiting. The study focuses on Traumatic Brain Injury. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mansoura University
Timeline & Enrollment
Phase 1/2
Mar 25, 2024
Mar 01, 2025
Primary Outcome
The early traumatic brain injury-related death in the hospital,The difference between treatment group in the Intracranial haemorrhage growth,The difference between the treatment groups in the incidence of mortality
Summary
Evaluate the effect of tranexamic acid on mortality in pediatric patients with traumatic
 brain injury. This could potentially lead to improved treatment protocols and better outcomes
 for this vulnerable population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06330935
Non-Device Trial